CN Patent

CN101809018B — (s)-2-氨基-3-(4-(2-氨基-6-((r)-1-(4-氯-2-(3-甲基-1h-吡唑-1-基)苯基)-2,2,2-三氟乙氧基)-嘧啶-4-基)苯基)丙酸乙酯的固体形式及其使用方法

Assigned to Desselay Biomedical Co Ltd · Expires 2013-02-06 · 13y expired

What this patent protects

本发明公开了(S)-2-氨基-3-(4-(2-氨基-6-((R)-1-(4-氯-2-(3-甲基-1H-吡唑-1-基)苯基)-2，2，2-三氟乙氧基)嘧啶-4-基)苯基)丙酸乙酯的固体形式及其盐。

USPTO Abstract

本发明公开了(S)-2-氨基-3-(4-(2-氨基-6-((R)-1-(4-氯-2-(3-甲基-1H-吡唑-1-基)苯基)-2，2，2-三氟乙氧基)嘧啶-4-基)苯基)丙酸乙酯的固体形式及其盐。

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: CN101809018B
Jurisdiction: CN
Classification: —
Expires: 2013-02-06
Drug substance claim: No
Drug product claim: No
Assignee: Desselay Biomedical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.